Dr. Matthias Schiedel



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Fluorescent Ligands Targeting the Intracellular Allosteric Binding Site of the Chemokine Receptor CCR2 (2022) Toy L, Huber M, Schmidt M, Weikert D, Schiedel M Journal article Development of a NanoBRET assay to validate inhibitors of Sirt2-mediated lysine deacetylation and defatty-acylation that block prostate cancer cell migration (2022) Vogelmann A, Schiedel M, Woessner N, Merz A, Herp D, Hammelmann S, Colcerasa A, et al. Journal article Comparison of Cellular Target Engagement Methods for the Tubulin Deacetylases Sirt2 and HDAC6: NanoBRET, CETSA, Tubulin Acetylation, and PROTACs (2022) Vogelmann A, Jung M, Hansen FK, Schiedel M Journal article, Review article A Chemical Biology Toolbox Targeting the Intracellular Binding Site of CCR9: Fluorescent Ligands, New Drug Leads and PROTACs (2022) Huber M, Toy L, Schmidt M, Vogt H, Budzinski J, Wiefhoff MFJ, Merten N, et al. Journal article Call for Papers: "epigenetics 2.0" - A Joint Virtual Special Issue on Epigenetics (2021) Bhatia S, Hansen FK, Schiedel M Journal article Validation of the Slow Off-Kinetics of Sirtuin-Rearranging Ligands (SirReals) by Means of Label-Free Electrically Switchable Nanolever Technology (2020) Schiedel M, Daub H, Itzen A, Jung M Journal article HaloTag-Targeted Sirtuin-Rearranging Ligand (SirReal) for the Development of Proteolysis-Targeting Chimeras (PROTACs) against the Lysine Deacetylase Sirtuin 2 (Sirt2) (2020) Schiedel M, Lehotzky A, Szunyogh S, Oláh J, Hammelmann S, Wössner N, Robaa D, et al. Journal article